Double-Blind, Randomized, Placebo-Controlled Study of Recombinant Human Tumor Necrosis Factor Receptor (p75) Fusion Protein Etanercept (Enbrel) in Patients With Moderate to Severe Plaque Psoriasis of the Hands and/or Feet.
Phase of Trial: Phase I/II
Latest Information Update: 13 Dec 2018
At a glance
- Drugs Etanercept (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 22 Jul 2008 New trial record.